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Abstract (175 words) 1 
Recommendations and guidelines on the prevention of food allergy have changed in recent 2 
decades. The aim of this review of the current evidence and on-going studies  is to provide a 3 
comprehensive picture of the current state of the art in this field for healthcare professionals. It 4 
was undertaken as part of the European Union funded iFAAM (Integrated Approaches to Food 5 
Allergy and Allergen Management) study. This is a wide-ranging project bringing together 6 
expertise across the breadth of food allergy research. Specifically, the review discusses dietary 7 
manipulation in food allergy prevention and covers the possible preventive strategies of allergen 8 
avoidance, early allergen introduction, general nutrition and supplements as well as other 9 
strategies such as pre- and  probiotics.. The review concludes that despite agreement that 10 
allergen avoidance strategies should not be undertaken for allergy prevention, there is currently 11 
no consensus regarding what actions should be recommended beyond exclusive breastfeeding 12 
for the first 4-6 months of life. Recent and up-coming trial results, which are detailed in this 13 
review, should help inform the debate and add clarity to the topic.   14 
  15 
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Introduction  1 
Food allergy affects all ages and has serious health consequences.[1] There has been 2 
speculation of its pathophysiology with research focussing on prevention. Additionally, there 3 
have been numerous recommendations from groups ranging from national health bodies to 4 
mothers’ “blogs” on how to prevent food allergy. This advice has changed over time causing 5 
confusion amongst healthcare professionals and the lay public.  6 
A further complication is the differing terminology used to define food reactions [2,3] This leads 7 
to conditions with differing immunological mechanisms being considered together under an 8 
umbrella term of ‘food allergy’ hindering identification of causative factors due to heterogeneity 9 
of cases studied.  10 
This manuscript aims to present an up to date review of current understanding of primary and 11 
secondary IgE-mediated food allergy prevention in relation to infant feeding (Figure 1). The 12 
recent publications of important randomised controlled trials (RCTs) makes this a timely review 13 
delivering a critical and independent overview of current evidence.  14 
 15 
Figure 1 Algorithm of the three stages of allergy prevention 16 
 17 
Allergenic food avoidance 18 
In 1906, the principle that an allergic reaction occurred on the second and subsequent 19 
exposures to the allergen following initial allergen priming was first proposed. This led to the 20 
concept that exposure to the food allergen early in an infant’s immunological development was 21 
important in food allergy initiation [4].  As knowledge in the field of immunology developed with 22 
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the concept of immunological sensitisation and the discovery of IgE it became clear that the first 1 
exposure could be in-utero or during breast-feeding. Consequently allergen avoidance became 2 
the primary strategy for allergy prevention with an idealised strategy for allergy prevention being 3 
published in 1983.[5] It aimed to avoid intra-uterine and post-natal sensitisation by minimising 4 
exposure to sensitising proteins during the third trimester of pregnancy, during lactation by 5 
recommending exclusive breast feeding of the infant (or fed an extensively hydrolysed infant 6 
formula) until 6 months of age. It then advocated the introduction of ‘relatively non-allergenic 7 
foods’ with milk, corn, citrus, legumes, egg, peanuts and fish introduction being delayed until 1 8 
to 3 years of age. RCTs using this strategy initially had encouraging results[6-9] so the concept 9 
of allergen avoidance for food allergy prevention continued into the late 1990’s with national and 10 
regional guidelines supporting these recommendations.[10,11]  11 
Early this century, allergy prevention research focussed on pregnancy,[12,13] environmental 12 
factors,[14,15] and infant feeding strategies.[16] Related research suggested acquiring 13 
tolerance to foreign (food) proteins was an active rather than a passive process.[17,18] 14 
Consequently, early introduction of allergenic foods into the diet ought not to lead to 15 
sensitisation or allergic disease.[19-21] This meant avoidance as an allergy prevention strategy 16 
was questioned. Additionally, newer publications from observational birth cohort studies[22-25] 17 
and subsequent systematic review[1] suggested evidence for recommending avoidance 18 
strategies in pregnancy and lactation was lacking and delaying solid introduction did not appear 19 
to protect against food allergy. Consequently, the latest recommendation for allergy prevention 20 
by the European Academy of Allergy and Clinical Immunology (EAACI) does not support 21 
avoidance as an allergy prevention strategy during pregnancy, lactation or complementary 22 
feeding.[26] The American Academy of Pediatrics (AAP),[27] the Australasian Society of Clinical 23 
Immunology and Allergy (ASCIA)[28] and other national bodies[29,30] have similar views. 24 
EAACI does however state that “current evidence does not justify any recommendations about 25 
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either withholding or encouraging exposure to potentially allergenic foods after 4 months once 1 
weaning has commenced”.[26] 2 
Introduction of allergenic foods 3 
The World Health Organisation (WHO) recommendation for  exclusive breastfeeding for the first 4 
six months with complementary feeding thereafter alongside breastfeeding to two years of age 5 
remains the basis for infant feeding recommendations in the UK and around much of the world 6 
but it should be remembered that their primary aim was to reduce GI infections and allergy 7 
prevention was not considered.[31]  The European Society for Paediatric Gastroenterology, 8 
Hepatology and Nutrition (ESPGHAN) committee recommends exclusive or full breastfeeding 9 
for about six months as a desirable goal. It also adds that complementary feeding should not 10 
start before 17 weeks but should have started by 26 weeks.[32] Meanwhile, advice from the 11 
USA and Australia states solid food introduction, including allergenic foods, may begin between 12 
four and six months.[27,28]  Feeding recommendations relating to allergenic foods also 13 
differs.[33] In practice, reported feeding practices vary, for example, 4% of infants are first 14 
introduced to solids before 4 months of age in Australia and Greece compared to 43% in the UK 15 
(Table 1).   16 
 17 
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Table 1. International reported practices of food introduction in infants  
Country Year Data 
collected 
Reference Proportion 
of infants  
introduced 
to solids 
before 4 
months 
Proportion of 
infants introduced 
to solids after 6 
months 
Proportion of infants 
introduced to allergenic foods 
before 6 months 
Proportion 
of infants 
introduced 
to allergenic 
foods by 8-
10 months 
Australia 2008-
2010 
Koplin et al 
2010[34]
 
4% 5%   
France 2003-
2006 
de Lauzon-
Guillain et al 
Am J Clin 
Nutr 
2013[35]
 
~30% ~30%   
Germany 2002-
2006 
Tromp et al 
Arch Pediatr 
Adolesc Med 
2011[36]
 
 55% 69% Cows milk; 21% Hen’s 
egg; 15% Peanut; 13% Tree 
nuts; 29% Soy 
 
Greece 2005-
2007 
de Lauzon-
Guillain et al 
Am J Clin 
Nutr 
2013[35]
 
~4% ~10%   
Ireland 
 
2008-
2012 
O’Donovan 
et al (37)
 
18% 
(<17weeks) 
3% (>26 weeks) 57% cow’s milk; 57% gluten 
[Wheat (39%); Barley (13%); 
Rye (16%)]; 40% soy, 8% egg; 
6% fish; 6% kiwi. 
n/a 
Portugal 2005-
2006 
De Lauzon-
Guillain et al 
Am J Clin 
Nutr 
2013[35]
 
~5% ~20%   
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UK 2010*
≠
 
 
 
 
 
2006-
2008
†
 
*Lennox et al 
2011[38]; 
≠
McAndrew 
et al IFS 
2010[39]; 
 
Grimshaw KE 
an  Roberts 
G  (40) 
 
43%* 
 
 
 
 
36.6%
†
 
 
 
 
 
 
1.7%
†
 
 
 
 
 
 
54% Cows milk; 42% wheat; 
10% Hens egg; 19% Fish; 6% 
Kiwi; 0.5% Peanut
†
 
8% (peanut)
≠
 
USA 2005-
2007 
Luccioli et al 
Pediatrics 
2014[41]
 
34%  70% Cows milk; 0.9% Hens 
egg; 0.5% Peanut; 0.7% Soy; 
0.2% Fish  
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Several observational studies have examined the association between age of complementary 1 
feeding and allergy development.[24,34,42-44] Unfortunately interpretation of these studies is 2 
limited by their heterogeneity, particularly regarding breastfeeding duration. This may prove to 3 
be more important than the duration of exclusive breastfeeding since there is  emerging data  of 4 
a possible protective effect on the development of allergy of solid  introduction with concurrent 5 
breastfeeding, [44, 45]. This supports the WHO recommendation that solid introduction should 6 
ideally take place alongside continued breastfeeding. [31] Additionally, there is initial evidence 7 
that introducing allergens as complementary foods and as part of a healthy diet is also 8 
protective. [46, 47] However, even well designed observational birth cohort studies cannot 9 
determine causality, only associations.  Nevertheless, anecdotal or observational evidence 10 
points to lower allergy rates in countries where consumption of dietary allergens as 11 
complementary foods starts at an earlier age.[42-44;48]4 Evidence from large-scale RCTs is 12 
required to assess whether there is a causal relationship between early consumption and 13 
reduced food allergy risk and a number of RCTs have been established with the aim of 14 
addressing this.   15 
Three of these RCTs have reported fully: STAR, LEAP and EAT studies. The STAR study 16 
enrolled 86 high-risk infants aged 4 to 6 months with moderate/severe eczema[49]. Of the 17 
infants randomised to receive egg powder, 31% had an allergic reaction to the egg powder 18 
leading to the study being stopped prematurely. At 12 months of age, there was a trend in this 19 
small study towards fewer infants randomised to the egg ingestion group being diagnosed with 20 
IgE mediated food allergy (33% versus 51%, p=0.11).  21 
Initial findings from the LEAP study, which enrolled 530 high-risk infants with moderate/severe 22 
eczema and/or egg allergy aged 4 to 11 months, have been reported [50]. They demonstrated 23 
that of infants randomised to open-label peanut consumption, 1.9% had peanut allergy 24 
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determined by double-blind, placebo-controlled challenge at age 5 years compared to 13.7% in 1 
the control group who avoided peanuts (p<0.001). In a second group of 98 high-risk infants from 2 
the LEAP study with a 1-4mm skin prick test wheal to peanut, 10.6% of the early consumption 3 
group developed peanut allergy compared to 35.3% in the avoidance group (p=0.004). The 4 
findings from this study led to a consensus communication giving interim guidance on early 5 
peanut introduction and the prevention of peanut allergy in high-risk infants.[51] Recently a 6 
follow up to the LEAP study (“LEAP-ON” Study) has been published [52]. The participants were 7 
reassessed for peanut allergy after all being on a peanut avoidance diet for a year. Peanut 8 
allergy at 6 years continued to be much more prevalent in the LEAP avoiders than consumers 9 
(18.6% versus 4.8%, p<0.001) and there was no increase in peanut allergy in the LEAP 10 
consumption arm. These results suggest that early introduction of peanut into the diet may 11 
induce long term tolerance.  12 
The EAT study focused on the early introduction of six common food allergens into the diet of 13 
1303 breastfed 3 month old infants recruited from a general (not high-risk ) population. [53] In 14 
an intention to treat analysis, 7.1% of the standard introduction group and 5.6% of the early 15 
introduction group developed food allergy to one or more of the six intervention foods (peanut, 16 
egg, cows milk, sesame, white fish and wheat) up to 3 years of age (p=0.32). However, when 17 
the analysis was adjusted for adherence to early introduction, ther  was a statistically significant 18 
reduction in food allergy in the early introduction group (6.4% versus 2.4%, p=0.03), suggesting 19 
introduction of sufficient amounts of allergenic foods into the infant diet from three to six months 20 
alongside continued breastfeeding may be effective in food allergy prevention. However, the 21 
poor adherence to study protocol emphasises the challenges around introducing solids into the 22 
diets of infants under six months of age.   23 
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Four of the five on-going studies have been completed but their findings have not yet been 1 
published. The final two will be completed over the next few years (Table 2). The four  2 
completed studies all looked at early introduction of egg in the general population (HEAP) and in 3 
children at moderate-risk of developing an allergy (BEAT, PETIT and STEP). They have similar 4 
study designs and large enrolment numbers. HEAP has reported limited results in a conference 5 
abstract [54] and symposium presentation with a conclusion that early consumption of hens egg 6 
was not effective in preventing hens egg allergy, but full results are awaited. BEAT and PETIT 7 
have also made a preliminary reports in abstract form. PETIT reported a scheduled interim 8 
analysis which showed a significant difference in prevalence of egg allergy in the intention-to-9 
treat analysis (37.7% in placebo group and 8.3% in egg group (p=0.0013) with no significant 10 
difference in adverse events between the groups.[55] BEAT findings showed a significant 11 
reduction in egg skin test sensitisation rates and higher egg specific IgG4/IgE  in infants who 12 
had egg introduced between 4-6 months compared with those introduced after 8 months. They 13 
reported no difference in clinical egg allergy and a significant rate of egg allergic reactions on 14 
initial exposure in the infants randomised to receive egg, suggesting many at risk infants may 15 
already be allergic and not be amenable to early introduction of egg by 4-5 months of age. [56] 16 
The PEAAD Study will look at early peanut consumption in infants with eczema and a high risk 17 
of developing a peanut allergy. Children in this study are not randomly assigned to the 18 
intervention/control groups, instead, the carer chooses whether their child will consume or avoid 19 
peanut. The age when children begin peanut consumption is wider than in the LEAP Study thus 20 
providing data on the impact of peanut introduction beyond the first year of life. Finally, the 21 
PreventADALL study will assess the impact of the introduction of four allerge ic foods by 4 22 
months, and/or emollient use to 9 months of age on food allergy development. All these studies 23 
address slightly different populations in terms of allergy risk, resulting in a broad picture across 24 
the atopic risk spectrum. Data from all these trials will be brought together in the EU-funded 25 
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Integrated Food Allergy and Allergen Management (iFAAM) project to provide advice on allergy 1 
prevention strategies for clinicians and families.    2 
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Table 2. Summary of current studies investigating the hypothesis that the early introduction of allergenic foods can induce oral 
tolerance 
Name of Trial Country 
(institution) 
Allergen(s) 
of interest 
Population Study details Study 
status 
Enquiring About 
Tolerance (EAT) 
UK (Kings 
College, London) 
Cows’ milk, 
hens’ egg, 
peanut, cod, 
sesame, 
wheat 
General 
population 
• Open-label RCT  
• n = 1106  
• Enrolled at 3 months of age then consumption of 6 
allergenic foods until 6 months or exclusive breastfeeding 
until 6 months of age 
• Outcome: prevalence of IgE-mediated food allergy to any 
of the 6 allergenic foods between 1 and 3 years of age 
Reported 
Learning Early 
About Peanut 
allergy (LEAP) 
UK (Kings 
College, London) 
Peanut High-risk (infants 
with moderate / 
severe eczema 
and / or egg 
allergy) 
• Open-label RCT 
•  n = 640 
• Enrolled at 4-11 months then peanut consumption or 
avoidance until age 5 
• Outcome: prevalence of DBPCFC  confirmed peanut 
allergy at 5 years of age 
Reported 
Hens’ Egg Allergy 
Prevention 
(HEAP) 
Germany 
(Charite Hospital, 
Berlin) 
Hens’ egg General 
population 
• RCT, placebo controlled 
• n ~ 800 
• Enrolled at 4-6 months then consumption of egg powder 
or placebo until 12 months of age 
• Outcome: prevalence of IgE-mediated egg allergy at 12 
months of age 
 
Completed. 
Abstract 
presented 
[54] 
Preventing Peanut 
Allergy in Atopic 
Dermatitis 
(PEAAD) 
Germany 
(Charite Hospital, 
Berlin) 
Peanut High-risk (infants 
with atopic 
dermatitis) 
• Non-randomized, self-selected 
• n~460 
• Enrolled at 5-30 months of age then peanut consumption 
or avoidance for 1 year 
• Outcome: prevalence of IgE-mediated peanut allergy after 
1 year of enrolment 
Ongoing 
Prevention of egg 
allergy in infants 
with atopic 
dermatitis 
(PETIT) 
Japan (National 
Center for child 
Health and 
Development, 
Japan) 
Hens’ egg High-risk (infants 
with atopic 
dermatitis) 
• RCT, placebo controlled 
• n ~ 200 
• Enrolled at 4-6 months then consumption of egg 
powder or placebo until 12 months of age 
• Outcome: prevalence of IgE-mediated egg allergy 
at 12 months of age 
Completed. 
Abstract 
presented 
Solids Timing for 
Allergy Research 
Australia 
(University of 
Hens’ egg High-risk (infants 
with moderate / 
• RCT, placebo controlled 
• n = 86 
Reported 
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(STAR) Western 
Australia) 
severe eczema) • Enrolled at 4-6 months of age then consumption of egg 
powder or placebo until 8 months of age   
• Outcome: prevalence of IgE-mediated egg allergy at 12 
months of age 
Starting Time for 
Egg Protein 
(STEP) 
Australia 
(University of 
Western 
Australia) 
Hens’ egg Moderate-risk 
(infants without 
eczema but 
atopic mothers) 
• RCT, placebo controlled 
• n~1500 
• Enrolled at 4-6 months of age then consumption of egg 
powder or placebo until 12 months of age 
• Outcome: prevalence of IgE-mediated egg allergy at 12 
months of age 
 
Completed 
Beating Egg 
Allergy (BEAT) 
Australia 
(Sydney 
University 
(Children’s 
Hospital, ) 
Hens’ egg Moderate-risk 
(sibling / parent 
with allergy) 
• RCT, placebo controlled 
• n~290 
• Enrolled at 4 months of age then consumption of egg 
powder or placebo until 8 months of age 
• Outcome:primary-  egg white sensitisation. Secondary-
prevalence of IgE-mediated egg allergy at 12 months of 
age 
 
Completed 
Preventing atopic 
dermatitis and 
allergies in 
children  
 (PreventADALL) 
Norway (Oslo 
University 
Hospital) 
Hen’s egg, 
milk, wheat, 
peanut 
General 
population 
• Open label RCT with four arms: observation, early 
introduction by 4 months, skin care, both early introduction 
and skin care 
• N=5200 
• Outcome: food allergy, atopic dermatitis 
Ongoing 
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Micronutrients and allergy prevention 1 
Since most food allergens are proteins, these have usually been the focus of food allergy 2 
prevention research. However, with increased knowledge of the role of macro- and micro-3 
nutrients in immunological processes, there is increasing interest in the relationship between 4 
dietary nutrients and the development of allergic conditions. Observational data linking delayed 5 
allergen introduction and increased allergy rates may also be explained by the reduced intake of 6 
immunologically active nutrients.[19,34,57,58] Polyunsaturated fatty acids (PUFAs), anti-7 
oxidants (selenium, vitamins A, C, E and β–carotene), vitamin D, iron, zinc and folate are of 8 
particular interest for allergy prevention.[59-67]  9 
 10 
To date, PUFAs have been the most extensively studied immuno-modulatory nutrient. 11 
Observational studies have related increased intake of omega–3-rich foods during pregnancy, 12 
lactation and infancy with decreased risk of allergic disease.[58,67] However, interventional 13 
study findings have been inconsistent, possibly due to small sample sizes and heterogeneous 14 
allergy outcomes. A recent Cochrane review looked at eight randomised control trials of omega-15 
3 PUFA supplementation during pregnancy (5 trials), lactation (2 trials) or both (1 trial). 16 
Supplementation showed a clear reduction in any IgE mediated allergy in children aged 12-36 17 
months but not beyond 36 months. For specific allergies there was no clear difference for food 18 
allergies at 12-36 months but a clear reduction was seen for children up to 12 months of age. 19 
The author conclude “there is limited evidence to support maternal n-3 LCPUFA supplementation 20 
during pregnancy and/or lactation for reducing allergic disease in children”.[68] Large intervention trials 21 
(completed or on-going; Table 3) may further clarify the association between PUFAs and food 22 
allergy development.[69-72] 23 
 24 
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Vitamin D has received considerable attention in recent years with a suggestion that vitamin D 1 
supplementation and/or food fortification is the cause of increasing allergic disease 2 
prevalence[73] with observed associations between high maternal and infant vitamin D status 3 
and allergic disease[74,75] supporting this theory. Conversely, latitudinal differences in auto-4 
injector prescriptions for food-induced anaphylaxis [76] and hypoallergenic infant formula 5 
use[77] have suggested a causal link with low vitamin D status. Associations between vitamin D 6 
intake and status and allergic disease risk are from a diverse literature, including cross-7 
sectional, case-control and cohort studies, with variable outcome definitions, analytical 8 
procedures and study quality.[74,75,78-81]  However, the HealthNuts study, which used a 9 
validated food allergy outcome measure, showed that low vitamin D status may be a risk factor 10 
for infant food allergy.[82] The VITALITY trial (NCT02112734) is currently looking at the impact 11 
of infant vitamin D supplementation on food allergy prevalence at 1 year.  12 
Lower intakes of antioxidants are suggested to reduce antioxidant defences and increase the 13 
risk of atopic disease.[83-87] In particular, vitamins A, E and C and zinc may confer some 14 
protection. However, appropriately designed controlled studies are required to establish if there 15 
is a causal relationship.[88]   16 
Differing reports of observed associations between immune-modulatory nutrients and allergic 17 
disease may be explained by the fact that the whole diet rather than one particular nutrient 18 
modifies immunological function. This hypothesis is supported by a number of studies that have 19 
found an association between the whole diet, (including diversity), and allergic disease.[46, 47, 20 
89-90] Additionally, recent research demonstrated that an infant diet consisting of high levels of 21 
fruits, vegetables, and home-prepared foods was associated with less food allergy by the age of 22 
2 years.[46] This inverse association with processed foods has been observed elsewhere[89] 23 
and may be due to the higher microbial load of home processed foods compared to 24 
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commercially prepared foods[92] or that home processed fruits and vegetables are good 1 
sources of naturally occurring prebiotics. Both are thought to modify immune function.[93] 2 
Other strategies for preventing food allergy 3 
Hypoallergenic infant formula  4 
In new-borns, the mucosal barrier is immature and large quantities of macromolecules cross the 5 
epithelium into systemic circulation.  Intestinal permeability reduces with age but in the first few 6 
months of life when combined with the immature status of the immune system, it is considered a 7 
risk factor for food allergy development and this is the period when standard infant formula is 8 
given if breastfeeding isn’t possible. Therefore, if breastfeeding isn’t  possible, it is 9 
recommended that high-risk children (parent or sibling with a history of allergy) use a 10 
hypoallergenic cow’s milk protein (HA) formula to avoid early exposure to intact milk 11 
allergens.[27,28] 12 
HA formulas are processed to reduce the allergenicity of milk proteins by ‘snipping’ them into 13 
smaller pieces (peptides). They are differentiated into extensively and partially hydrolysed 14 
formulas (eHF and pHF respectively). eHF contain predominantly small milk-derived peptides 15 
with almost no allergenicity, whereas pHFs also contain larger milk-derived peptides. eHFs were 16 
originally produced to treat milk-allergic infants but are now also used for allergy 17 
prevention,[94,95] whereas pHFs are produced only for allergy prevention.  18 
Studies indicate that some pHF and eHF can reduce the risk of food allergy development but 19 
other studies failed to demonstrate a protective effect.[26] Consequently, there is debate as to 20 
which is the best formula for allergy prevention as reflected by differing national and 21 
professional body recommendations[25-29] and individual clinicians’ opinions.[96,97] 22 
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However, a recent systematic review and meta-analysis, using a rigorous approach, failed to 1 
find a beneficial effect of hypoallergenic infant formulas on food allergy.[98] The authors 2 
highlighted that many studies were at uncertain or high risk of bias, they also found evidence of 3 
publication bias. They argued that earlier reviews have been influenced by the more positive 4 
results from lower quality design studies.  Since it appears preventive efficacy is highly 5 
dependent on the specific formula studied, the EAACI guidelines group recommended the use 6 
of HA formulas with a documented preventive effect for high-risk children in the first 4 months of 7 
life only.[26] No studies show a preventive effect in low-risk children. 8 
 9 
Prebiotics and probiotics  10 
The microbiota of infants with atopic disease is both quantitatively and qualitatively different[99] 11 
from their non-atopic counterparts, with decreased populations of beneficial bacteria 12 
(bifidobacteria, bacteroides, and lactobacilli and higher numbers of coliforms and S. 13 
aureus.[100]. This has promoted research into the role of intestinal microbiota in the 14 
development of immune tolerance. Lower consumption of prebiotics (fibre/indigestible dietary 15 
components) are suggested to lead to less favourable colonization patterns which may be 16 
implicated in the loss or inability to develop oral tolerance. Neonatal prebiotic supplementation 17 
trials have failed to show any effect of prebiotics on food allergy development but have shown 18 
favourable results on other allergic outcomes such as eczema. [101] RCTs assessing the 19 
effects of probiotics in the prevention of eczema, and/or food allergy have reported differing 20 
findings.[102-10106]. The most up to date Cochrane review on the subject states that further 21 
research is needed before probiotic use can be recommended for allergy prevention.[107] 22 
However, a recent World Allergy Organisation (WAO) systematic review has suggested using 23 
probiotics in infants at high risk of allergy due to the “likely net benefit” from the prevention of 24 
Page 18 of 66
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
19 
 
eczema seen with the use of probiotics.[108] The guideline panel did however acknowledge that 1 
their recommendation was supported by very low quality evidence demonstrating a need for 2 
high quality intervention trials and there a number of these ongoing (Table 3) which may provide 3 
further insight in the future. These studies will also provide information on which strains may be 4 
the most effective for allergy prevention and what dose is required as these are important 5 
factors to consider and about which there is currently very little information.   6 
 7 
  8 
 9 
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Table 3. Intervention trials with food allergy as a primary or secondary outcome 
Nutrient Study Name Location Recruitment 
Status 
Identifier 
Vitamin D The VITALITY trial Australia Recruiting NCT02112734 
Vitamin A Vitamin A supplementation at birth and atopy in 
childhood 
Guinea Bissau Active NCT01779180 
PUFAs DHA to optimise mother infant outcomes 
(DOMInO) trial 
Australia Completed ACTRN12605000569606 
PUFAs The infant fish oil supplementation (IFOS) trial  Australia Active ACTRN12606000281594 
PUFAs Can supplementation with Lactobacillus reuteri and 
Omega-3 fatty acids during pregnancy and 
lactation reduce the risk of allergic disease in 
infancy? (PROOM-3)* 
Sweden Recruiting NCT01542970 
Probiotics Primary prevention of atopic disease by perinatal 
administration of probiotics  
Netherlands Completed NCT00200954 
Probiotics Influence of probiotics on atopy, immunological 
responses and gut microflora, follow-up to 5 years 
Singapore Completed NCT00365469 
Probiotics Microbiota as a potential target for food allergy Italy Recruiting NCT02087930 
Probiotics Effect of lactobacillus GG on atopic march Italy Recruiting NCT01891916 
Prebiotic Prebiotics in the prevention of atopy (PIPA) Italy Completed NCT02116452 
† atopic sensitization; Se: selenium; Fe: Iron; Zn: Zinc 
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 1 
Figure 2 Early factors and mechanisms that interact to prevent or favour the development of an allergic 2 
response to a food protein 3 
 4 
 5 
6 
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Summary and conclusions 1 
This review covered a number of approaches to prevent the development of food allergy. These are likely to 2 
interact. Figure 2 summarises how factors (including prenatal factors which have not been considered in this 3 
review) may interact to prevent or promote the food allergy development. Unlike in previous decades, national 4 
recommendations for food allergy prevention strategies now largely agree, particularly concerning hypoallergenic 5 
formula use and not delaying the introduction of allergenic foods. [26-29] However, while there is consensus that 6 
avoidance strategies are ineffective, guidelines do not provide any alternative strategies. There is a call for more 7 
high-quality data from robust RCTs. Some has already been provided and appears to support the concept that 8 
early consumption of allergenic food promotes the development of immune tolerance and a recent consensus 9 
statement supports this[47].  However, before recommendations are updated, it is important to understand how 10 
best to introduce preventive interventions in a community context, particularly since there may be significant 11 
numbers of children already sensitised by the time they are weaned. Given their different intervention strategies 12 
and populations investigated, combining the new RCT data into meta- or pooled analyses, will broaden their 13 
informational scope, and this is planned as part of the iFAAM study. However, even pooled, they may not 14 
provide data as to what dose of allergenic food should be given and for how long. Data from on-going studies on 15 
solid food introduction and nutritional supplementation may also provide a broader understanding of food allergy 16 
prevention. As studies have generally only focused on IgE mediated food allergy, their findings may not be 17 
applicable to preventing the development of non-IgE mediated food allergy conditions such as eosinophilic 18 
oesophagitis and food protein induced enterocolitis syndrome. Aetiology data for these conditions are lacking 19 
and RCTs similar to those carried out for IgE-mediated disease should be a future research priority in the field of 20 
food allergy.  21 
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Abstract (175 words) 1 
Recommendations and guidelines on the prevention of food allergy have changed in recent 2 
decades. The aim of this review of the current evidence and on-going studies  is to provide a 3 
comprehensive picture of the current state of the art in this field for healthcare professionals. It 4 
was undertaken as part of the European Union funded iFAAM (Integrated Approaches to Food 5 
Allergy and Allergen Management) study. This is a wide-ranging project bringing together 6 
expertise across the breadth of food allergy research. Specifically, the review discusses dietary 7 
manipulation in food allergy prevention and covers the possible preventive strategies of allergen 8 
avoidance, early allergen introduction, general nutrition and supplements as well as other 9 
strategies such as pre- and probiotics.. The review concludes that despite agreement that 10 
allergen avoidance strategies should not be undertaken for allergy prevention, there is currently 11 
no consensus regarding what actions should be recommended beyond exclusive breastfeeding 12 
for the first 4-6 months of life. Recent and up-coming trial results, which are detailed in this 13 
review, should help inform the debate and add clarity to the topic.   14 
  15 
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Introduction  1 
Food allergy affects all ages and has serious health consequences.[1] There has been 2 
speculation of its pathophysiology with research focussing on prevention. Additionally, there 3 
have been numerous recommendations from groups ranging from national health bodies to 4 
mothers’ “blogs” on how to prevent food allergy. This advice has changed over time causing 5 
confusion amongst healthcare professionals and the lay public.  6 
A further complication is the differing terminology used to define food reactions [2,3] This leads 7 
to conditions with differing immunological mechanisms being considered together under an 8 
umbrella term of ‘food allergy’ hindering identification of causative factors due to heterogeneity 9 
of cases studied.  10 
This manuscript aims to present an up to date review of current understanding of primary and 11 
secondary IgE-mediated food allergy prevention in relation to infant feeding (Figure 1). The 12 
recent publications of important randomised controlled trials (RCTs) makes this a timely review 13 
delivering a critical and independent overview of current evidence.  14 
 15 
Figure 1 Algorithm of the three stages of allergy prevention 16 
 17 
Allergenic food avoidance 18 
In 1906, the principle that an allergic reaction occurred on the second and subsequent 19 
exposures to the allergen following initial allergen priming was first proposed. This led to the 20 
concept that exposure to the food allergen early in an infant’s immunological development was 21 
important in food allergy initiation [4].  As knowledge in the field of immunology developed with 22 
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the concept of immunological sensitisation and the discovery of IgE it became clear that the first 1 
exposure could be in-utero or during breast-feeding. Consequently allergen avoidance became 2 
the primary strategy for allergy prevention with an idealised strategy for allergy prevention being 3 
published in 1983.[5] It aimed to avoid intra-uterine and post-natal sensitisation by minimising 4 
exposure to sensitising proteins during the third trimester of pregnancy, during lactation by 5 
recommending exclusive breast feeding of the infant (or fed an extensively hydrolysed infant 6 
formula) until 6 months of age. It then advocated the introduction of ‘relatively non-allergenic 7 
foods’ with milk, corn, citrus, legumes, egg, peanuts and fish introduction being delayed until 1 8 
to 3 years of age. RCTs using this strategy initially had encouraging results[6-9] so the concept 9 
of allergen avoidance for food allergy prevention continued into the late 1990’s with national and 10 
regional guidelines supporting these recommendations.[10,11]  11 
Early this century, allergy prevention research focussed on pregnancy,[12,13] environmental 12 
factors,[14,15] and infant feeding strategies.[16] Related research suggested acquiring 13 
tolerance to foreign (food) proteins was an active rather than a passive process.[17,18] 14 
Consequently, early introduction of allergenic foods into the diet ought not to lead to 15 
sensitisation or allergic disease.[19-21] This meant avoidance as an allergy prevention strategy 16 
was questioned. Additionally, newer publications from observational birth cohort studies[22-25] 17 
and subsequent systematic review[1] suggested evidence for recommending avoidance 18 
strategies in pregnancy and lactation was lacking and delaying solid introduction did not appear 19 
to protect against food allergy. Consequently, the latest recommendation for allergy prevention 20 
by the European Academy of Allergy and Clinical Immunology (EAACI) does not support 21 
avoidance as an allergy prevention strategy during pregnancy, lactation or complementary 22 
feeding.[26] The American Academy of Pediatrics (AAP),[27] the Australasian Society of Clinical 23 
Immunology and Allergy (ASCIA)[28] and other national bodies[29,30] have similar views. 24 
EAACI does however state that “current evidence does not justify any recommendations about 25 
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either withholding or encouraging exposure to potentially allergenic foods after 4 months once 1 
weaning has commenced”.[26] 2 
Early Introduction of allergenic foods 3 
The World Health Organisation (WHO) recommendation for  exclusive breastfeeding for the first 4 
six months with complementary feeding thereafter alongside breastfeeding to two years of age 5 
remains the basis for infant feeding recommendations in the UK and around much of the world 6 
but it should be remembered that their primary aim was to reduce GI infections and allergy 7 
prevention was not considered.[31]  The European Society for Paediatric Gastroenterology, 8 
Hepatology and Nutrition (ESPGHAN) committee recommends exclusive or full breastfeeding 9 
for about six months as a desirable goal. It also adds that complementary feeding should not 10 
start before 17 weeks but should have started by 26 weeks.[32] Meanwhile, advice from the 11 
USA and Australia states solid food introduction, including allergenic foods, may begin between 12 
four and six months.[27,28]  Feeding recommendations relating to allergenic foods also 13 
differs.[33] In practice, reported feeding practices vary, for example, 4% of infants are first 14 
introduced to solids before 4 months of age in Australia and Greece compared to 43% in the UK 15 
(Table 1).   16 
 17 
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Table 1. International reported practices of food introduction in infants  
Country Year Data 
collected 
Reference Proportion 
of infants  
introduced 
to solids 
before 4 
months 
Proportion of 
infants introduced 
to solids after 6 
months 
Proportion of infants 
introduced to allergenic foods 
before 6 months 
Proportion 
of infants 
introduced 
to allergenic 
foods by 8-
10 months 
Australia 2008-
2010 
Koplin et al 
2010[34]
 
4% 5%   
France 2003-
2006 
de Lauzon-
Guillain et al 
Am J Clin 
Nutr 
2013[35]
 
~30% ~30%   
Germany 2002-
2006 
Tromp et al 
Arch Pediatr 
Adolesc Med 
2011[36]
 
 55% 69% Cows milk; 21% Hen’s 
egg; 15% Peanut; 13% Tree 
nuts; 29% Soy 
 
Greece 2005-
2007 
de Lauzon-
Guillain et al 
Am J Clin 
Nutr 
2013[35]
 
~4% ~10%   
Ireland 
 
2008-
2012 
O’Donovan 
et al (37)
 
18% 
(<17weeks) 
3% (>26 weeks) 57% cow’s milk; 57% gluten 
[Wheat (39%); Barley (13%); 
Rye (16%)]; 40% soy, 8% egg; 
6% fish; 6% kiwi. 
n/a 
Portugal 2005-
2006 
De Lauzon-
Guillain et al 
Am J Clin 
Nutr 
2013[35]
 
~5% ~20%   
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UK 2010*
≠
 
 
 
 
 
2006-
2008
†
 
*Lennox et al 
2011[38]; 
≠
McAndrew 
et al IFS 
2010[39]; 
 
Grimshaw KE 
an  Roberts 
G  (40) 
 
43%* 
 
 
 
 
36.6%
†
 
 
 
 
 
 
1.7%
†
 
 
 
 
 
 
54% Cows milk; 42% wheat; 
10% Hens egg; 19% Fish; 6% 
Kiwi; 0.5% Peanut
†
 
8% (peanut)
≠
 
USA 2005-
2007 
Luccioli et al 
Pediatrics 
2014[41]
 
34%  70% Cows milk; 0.9% Hens 
egg; 0.5% Peanut; 0.7% Soy; 
0.2% Fish  
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Several observational studies have examined the association between age of complementary 1 
feeding and allergy development.[24,34,42-44] Unfortunately interpretation of these studies is 2 
limited by their heterogeneity, particularly regarding breastfeeding duration. This may prove to 3 
be more important than the duration of exclusive breastfeeding since there is emerging data  of 4 
a possible protective effect on the development of allergy of solid  introduction with concurrent 5 
breastfeeding, [44, 45]. This supports the WHO recommendation that solid introduction should 6 
ideally take place alongside continued breastfeeding. [31] Additionally, there is initial evidence 7 
that introducing allergens as complementary foods and as part of a healthy diet is also 8 
protective. [46, 47] However, even well designed observational birth cohort studies cannot 9 
determine causality, only associations.  Nevertheless, anecdotal or observational evidence 10 
points to lower allergy rates in countries where consumption of dietary allergens as 11 
complementary foods starts at an earlier age.[42-44;48]4 Evidence from large-scale RCTs is 12 
required to assess whether there is a causal relationship between early consumption and 13 
reduced food allergy risk and a number of RCTs have been established with the aim of 14 
addressing this.   15 
Three of these RCTs have reported fully: STAR, LEAP and EAT studies. The STAR study 16 
enrolled 86 high-risk infants aged 4 to 6 months with moderate/severe eczema[49]. Of the 17 
infants randomised to receive egg powder, 31% had an allergic reaction to the egg powder 18 
leading to the study being stopped prematurely. At 12 months of age, there was a trend in this 19 
small study towards fewer infants randomised to the egg ingestion group being diagnosed with 20 
IgE mediated food allergy (33% versus 51%, p=0.11).  21 
Initial findings from the LEAP study, which enrolled 530 high-risk infants with moderate/severe 22 
eczema and/or egg allergy aged 4 to 11 months, have been reported [50]. They demonstrated 23 
that of infants randomised to open-label peanut consumption, 1.9% had peanut allergy 24 
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determined by double-blind, placebo-controlled challenge at age 5 years compared to 13.7% in 1 
the control group who avoided peanuts (p<0.001). In a second group of 98 high-risk infants from 2 
the LEAP study with a 1-4mm skin prick test wheal to peanut, 10.6% of the early consumption 3 
group developed peanut allergy compared to 35.3% in the avoidance group (p=0.004). The 4 
findings from this study led to a consensus communication giving interim guidance on early 5 
peanut introduction and the prevention of peanut allergy in high-risk infants.[51] Recently a 6 
follow up to the LEAP study (“LEAP-ON” Study) has been published [52]. The participants were 7 
reassessed for peanut allergy after all being on a peanut avoidance diet for a year. Peanut 8 
allergy at 6 years continued to be much more prevalent in the LEAP avoiders than consumers 9 
(18.6% versus 4.8%, p<0.001) and there was no increase in peanut allergy in the LEAP 10 
consumption arm. These results suggest that early introduction of peanut into the diet may 11 
induce long term tolerance.  12 
The EAT study focused on the early introduction of six common food allergens into the diet of 13 
1303 breastfed 3 month old infants recruited from a general (not high-risk ) population. [53] In 14 
an intention to treat analysis, 7.1% of the standard introduction group and 5.6% of the early 15 
introduction group developed food allergy to one or more of the six intervention foods (peanut, 16 
egg, cows milk, sesame, white fish and wheat) up to 3 years of age (p=0.32). However, when 17 
the analysis was adjusted for adherence to early introduction, ther  was a statistically significant 18 
reduction in food allergy in the early introduction group (6.4% versus 2.4%, p=0.03), suggesting 19 
introduction of sufficient amounts of allergenic foods into the infant diet from three to six months 20 
alongside continued breastfeeding may be effective in food allergy prevention. However, the 21 
poor adherence to study protocol emphasises the challenges around introducing solids into the 22 
diets of infants under six months of age.   23 
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Four of the five on-going studies have been completed but their findings have not yet been 1 
published. The final two will be completed over the next few years (Table 2). The four completed 2 
studies all looked at early introduction of egg in the general population (HEAP) and in children at 3 
moderate-risk of developing an allergy (BEAT, PETIT and STEP). They have similar study 4 
designs a d large enrolment numbers. HEAP has reported limited results in a conference 5 
abstract [54] and symposium presentation with a conclusion that early consumption of hens egg 6 
was not effective in preventing hens egg allergy, but full results are awaited. BEAT and PETIT 7 
have also made a preliminary reports in abstract form. PETIT reported a scheduled interim 8 
analysis which showed a significant difference in prevalence of egg allergy in the intention-to-9 
treat analysis (37.7% in placebo group and 8.3% in egg group (p=0.0013) with no significant 10 
difference in adverse events between the groups.[55] BEAT findings showed a significant 11 
reduction in egg skin test sensitisation rates and higher egg specific IgG4/IgE  in infants who 12 
had egg introduced between 4-6 months compared with those introduced after 8 months. They 13 
reported no difference in clinical egg allergy and a significant rate of egg allergic reactions on 14 
initial exposure in the infants randomised to receive egg, suggesting many at risk infants may 15 
already be allergic and not be amenable to early introduction of egg by 4-5 months of age. [56] 16 
The PEAAD Study will look at early peanut consumption in infants with eczema and a high risk 17 
of developing a peanut allergy. Children in this study are not randomly assigned to the 18 
intervention/control groups, instead, the carer chooses whether their child will consume or avoid 19 
peanut. The age when children begin peanut consumption is wider than in the LEAP Study thus 20 
providing data on the impact of peanut introduction beyond the first year of life. Finally, the 21 
PreventADALL study will assess the impact of the introduction of four allerge ic foods by 4 22 
months, and/or emollient use to 9 months of age on food allergy development. All these studies 23 
address slightly different populations in terms of allergy risk, resulting in a broad picture across 24 
the atopic risk spectrum. Data from all these trials will be brought together in the EU-funded 25 
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Integrated Food Allergy and Allergen Management (iFAAM) project to provide advice on allergy 1 
prevention strategies for clinicians and families.    2 
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Table 2. Summary of current studies investigating the hypothesis that the early introduction of allergenic foods can induce oral 
tolerance 
Name of Trial Country 
(institution) 
Allergen(s) 
of interest 
Population Study details Study 
status 
Enquiring About 
Tolerance (EAT) 
UK (Kings 
College, London) 
Cows’ milk, 
hens’ egg, 
peanut, cod, 
sesame, 
wheat 
General 
population 
• Open-label RCT  
• n = 1106  
• Enrolled at 3 months of age then consumption of 6 
allergenic foods until 6 months or exclusive breastfeeding 
until 6 months of age 
• Outcome: prevalence of IgE-mediated food allergy to any 
of the 6 allergenic foods between 1 and 3 years of age 
Reported 
Learning Early 
About Peanut 
allergy (LEAP) 
UK (Kings 
College, London) 
Peanut High-risk (infants 
with moderate / 
severe eczema 
and / or egg 
allergy) 
• Open-label RCT 
•  n = 640 
• Enrolled at 4-11 months then peanut consumption or 
avoidance until age 5 
• Outcome: prevalence of DBPCFC  confirmed peanut 
allergy at 5 years of age 
Reported 
Hens’ Egg Allergy 
Prevention 
(HEAP) 
Germany 
(Charite Hospital, 
Berlin) 
Hens’ egg General 
population 
• RCT, placebo controlled 
• n ~ 800 
• Enrolled at 4-6 months then consumption of egg powder 
or placebo until 12 months of age 
• Outcome: prevalence of IgE-mediated egg allergy at 12 
months of age 
 
Completed. 
Abstract 
presented 
[54] 
Preventing Peanut 
Allergy in Atopic 
Dermatitis 
(PEAAD) 
Germany 
(Charite Hospital, 
Berlin) 
Peanut High-risk (infants 
with atopic 
dermatitis) 
• Non-randomized, self-selected 
• n~460 
• Enrolled at 5-30 months of age then peanut consumption 
or avoidance for 1 year 
• Outcome: prevalence of IgE-mediated peanut allergy after 
1 year of enrolment 
Ongoing 
Prevention of egg 
allergy in infants 
with atopic 
dermatitis 
(PETIT) 
Japan (National 
Center for child 
Health and 
Development, 
Japan) 
Hens’ egg High-risk (infants 
with atopic 
dermatitis) 
• RCT, placebo controlled 
• n ~ 200 
• Enrolled at 4-6 months then consumption of egg 
powder or placebo until 12 months of age 
• Outcome: prevalence of IgE-mediated egg allergy 
at 12 months of age 
Completed. 
Abstract 
presented 
[55] 
Solids Timing for 
Allergy Research 
Australia 
(University of 
Hens’ egg High-risk (infants 
with moderate / 
• RCT, placebo controlled 
• n = 86 
Reported 
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(STAR) Western 
Australia) 
severe eczema) • Enrolled at 4-6 months of age then consumption of egg 
powder or placebo until 8 months of age   
• Outcome: prevalence of IgE-mediated egg allergy at 12 
months of age 
Starting Time for 
Egg Protein 
(STEP) 
Australia 
(University of 
Western 
Australia) 
Hens’ egg Moderate-risk 
(infants without 
eczema but 
atopic mothers) 
• RCT, placebo controlled 
• n~1500 
• Enrolled at 4-6 months of age then consumption of egg 
powder or placebo until 12 months of age 
• Outcome: prevalence of IgE-mediated egg allergy at 12 
months of age 
 
Completed 
Beating Egg 
Allergy (BEAT) 
Australia 
(Sydney 
University 
(Children’s 
Hospital, ) 
Hens’ egg Moderate-risk 
(sibling / parent 
with allergy) 
• RCT, placebo controlled 
• n~290 
• Enrolled at 4 months of age then consumption of egg 
powder or placebo until 8 months of age 
• Outcome: primary-  egg white sensitisation. Secondary-
prevalence of IgE-mediated egg allergy at 12 months of 
age 
 
Completed. 
Abstract 
presented 
[57] 
Preventing atopic 
dermatitis and 
allergies in 
children  
 (PreventADALL) 
Norway (Oslo 
University 
Hospital) 
Hen’s egg, 
milk, wheat, 
peanut 
General 
population 
• Open label RCT with four arms: observation, early 
introduction by 4 months, skin care, both early introduction 
and skin care 
• N=5200 
• Outcome: food allergy, atopic dermatitis 
Ongoing 
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Micronutrients and allergy prevention 1 
Since most food allergens are proteins, these have usually been the focus of food allergy 2 
prevention research. However, with increased knowledge of the role of macro- and micro-3 
nutrients in immunological processes, there is increasing interest in the relationship between 4 
dietary nutrients and the development of allergic conditions. Observational data linking delayed 5 
allergen introduction and increased allergy rates may also be explained by the reduced intake of 6 
immunologically active nutrients.[19,34,57,58] Polyunsaturated fatty acids (PUFAs), anti-7 
oxidants (selenium, vitamins A, C, E and β–carotene), vitamin D, iron, zinc and folate are of 8 
particular interest for allergy prevention.[59-67]  9 
 10 
To date, PUFAs have been the most extensively studied immuno-modulatory nutrient. 11 
Observational studies have related increased intake of omega–3-rich foods during pregnancy, 12 
lactation and infancy with decreased risk of allergic disease.[58,67] However, interventional 13 
study findings have been inconsistent, possibly due to small sample sizes and heterogeneous 14 
allergy outcomes. A recent Cochrane review looked at eight randomised control trials of omega-15 
3 PUFA supplementation during pregnancy (5 trials), lactation (2 trials) or both (1 trial). 16 
Supplementation showed a clear reduction in any IgE mediated allergy in children aged 12-36 17 
months but not beyond 36 months. For specific allergies there was no clear difference for food 18 
allergies at 12-36 months but a clear reduction was seen for children up to 12 months of age. 19 
The author conclude “there is limited evidence to support maternal n-3 LCPUFA supplementation 20 
during pregnancy and/or lactation for reducing allergic disease in children”.[68] Large intervention trials 21 
(completed or on-going; Table 3) may further clarify the association between PUFAs and food 22 
allergy development.[69-72] 23 
 24 
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Vitamin D has received considerable attention in recent years with a suggestion that vitamin D 1 
supplementation and/or food fortification is the cause of increasing allergic disease 2 
prevalence[73] with observed associations between high maternal and infant vitamin D status 3 
and allergic disease[74,75] supporting this theory. Conversely, latitudinal differences in auto-4 
injector prescriptions for food-induced anaphylaxis [76] and hypoallergenic infant formula 5 
use[77] have suggested a causal link with low vitamin D status. Associations between vitamin D 6 
intake and status and allergic disease risk are from a diverse literature, including cross-7 
sectional, case-control and cohort studies, with variable outcome definitions, analytical 8 
procedures and study quality.[74,75,78-81]  However, the HealthNuts study, which used a 9 
validated food allergy outcome measure, showed that low vitamin D status may be a risk factor 10 
for infant food allergy.[82] The VITALITY trial (NCT02112734) is currently looking at the impact 11 
of infant vitamin D supplementation on food allergy prevalence at 1 year.  12 
Lower intakes of antioxidants are suggested to reduce antioxidant defences and increase the 13 
risk of atopic disease.[83-87] In particular, vitamins A, E and C and zinc may confer some 14 
protection. However, appropriately designed controlled studies are required to establish if there 15 
is a causal relationship.[88]   16 
Differing reports of observed associations between immune-modulatory nutrients and allergic 17 
disease may be explained by the fact that the whole diet rather than one particular nutrient 18 
modifies immunological function. This hypothesis is supported by a number of studies that have 19 
found an association between the whole diet, (including diversity), and allergic disease.[46, 47, 20 
89-90] Additionally, recent research demonstrated that an infant diet consisting of high levels of 21 
fruits, vegetables, and home-prepared foods was associated with less food allergy by the age of 22 
2 years.[46] This inverse association with processed foods has been observed elsewhere[89] 23 
and may be due to the higher microbial load of home processed foods compared to 24 
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commercially prepared foods[92] or that home processed fruits and vegetables are good 1 
sources of naturally occurring prebiotics. Both are thought to modify immune function.[93] 2 
Other strategies for preventing food allergy 3 
Hypoallergenic infant formula  4 
In new-borns, the mucosal barrier is immature and large quantities of macromolecules cross the 5 
epithelium into systemic circulation.  Intestinal permeability reduces with age but in the first few 6 
months of life when combined with the immature status of the immune system, it is considered a 7 
risk factor for food allergy development and this is the period when standard infant formula is 8 
given if breastfeeding isn’t possible. Therefore, if breastfeeding isn’t  possible, it is 9 
recommended that high-risk children (parent or sibling with a history of allergy) use a 10 
hypoallergenic cow’s milk protein (HA) formula to avoid early exposure to intact milk 11 
allergens.[27,28] 12 
HA formulas are processed to reduce the allergenicity of milk proteins by ‘snipping’ them into 13 
smaller pieces (peptides). They are differentiated into extensively and partially hydrolysed 14 
formulas (eHF and pHF respectively). eHF contain predominantly small milk-derived peptides 15 
with almost no allergenicity, whereas pHFs also contain larger milk-derived peptides. eHFs were 16 
originally produced to treat milk-allergic infants but are now also used for allergy 17 
prevention,[94,95] whereas pHFs are produced only for allergy prevention.  18 
Studies indicate that some pHF and eHF can reduce the risk of food allergy development but 19 
other studies failed to demonstrate a protective effect.[26] Consequently, there is debate as to 20 
which is the best formula for allergy prevention as reflected by differing national and 21 
professional body recommendations[25-29] and individual clinicians’ opinions.[96,97] 22 
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However, a recent systematic review and meta-analysis, using a rigorous approach, failed to 1 
find a beneficial effect of hypoallergenic infant formulas on food allergy.[98] The authors 2 
highlighted that many studies were at uncertain or high risk of bias, they also found evidence of 3 
publication bias. They argued that earlier reviews have been influenced by the more positive 4 
results from lower quality design studies.  Since it appears preventive efficacy is highly 5 
dependent on the specific formula studied, the EAACI guidelines group recommended the use 6 
of HA formulas with a documented preventive effect for high-risk children in the first 4 months of 7 
life only.[26] No studies show a preventive effect in low-risk children. 8 
 9 
Prebiotics and probiotics  10 
The microbiota of infants with atopic disease is both quantitatively and qualitatively different[99] 11 
from their non-atopic counterparts, with decreased populations of beneficial bacteria 12 
(bifidobacteria, bacteroides, and lactobacilli and higher numbers of coliforms and S. 13 
aureus.[100]. This has promoted research into the role of intestinal microbiota in the 14 
development of immune tolerance. Lower consumption of prebiotics (fibre/indigestible dietary 15 
components) are suggested to lead to less favourable colonization patterns which may be 16 
implicated in the loss or inability to develop oral tolerance. Neonatal prebiotic supplementation 17 
trials have failed to show any effect of prebiotics on food allergy development but have shown 18 
favourable results on other allergic outcomes such as eczema. [101] RCTs assessing the 19 
effects of probiotics in the prevention of eczema, and/or food allergy have reported differing 20 
findings.[102-10106]. The most up to date Cochrane review on the subject states that further 21 
research is needed before probiotic use can be recommended for allergy prevention.[107] 22 
However, a recent World Allergy Organisation (WAO) systematic review has suggested using 23 
probiotics in infants at high risk of allergy due to the “likely net benefit” from the prevention of 24 
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eczema seen with the use of probiotics.[108] The guideline panel did however acknowledge that 1 
their recommendation was supported by very low quality evidence demonstrating a need for 2 
high quality intervention trials and there a number of these ongoing (Table 3) which may provide 3 
further insight in the future. These studies will also provide information on which strains may be 4 
the most effective for allergy prevention and what dose is required as these are important 5 
factors to consider and about which there is currently very little information.   6 
 7 
  8 
 9 
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Table 3. Intervention trials with food allergy as a primary or secondary outcome 
Nutrient Study Name Location Recruitment 
Status 
Identifier 
Vitamin D The VITALITY trial Australia Recruiting NCT02112734 
Vitamin A Vitamin A supplementation at birth and atopy in 
childhood 
Guinea Bissau Active NCT01779180 
PUFAs DHA to optimise mother infant outcomes 
(DOMInO) trial 
Australia Completed ACTRN12605000569606 
PUFAs The infant fish oil supplementation (IFOS) trial  Australia Active ACTRN12606000281594 
PUFAs Can supplementation with Lactobacillus reuteri and 
Omega-3 fatty acids during pregnancy and 
lactation reduce the risk of allergic disease in 
infancy? (PROOM-3)* 
Sweden Recruiting NCT01542970 
Probiotics Primary prevention of atopic disease by perinatal 
administration of probiotics  
Netherlands Completed NCT00200954 
Probiotics Influence of probiotics on atopy, immunological 
responses and gut microflora, follow-up to 5 years 
Singapore Completed NCT00365469 
Probiotics Microbiota as a potential target for food allergy Italy Recruiting NCT02087930 
Probiotics Effect of lactobacillus GG on atopic march Italy Recruiting NCT01891916 
Prebiotic Prebiotics in the prevention of atopy (PIPA) Italy Completed NCT02116452 
† atopic sensitization; Se: selenium; Fe: Iron; Zn: Zinc 
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 1 
Figure 2 Early factors and mechanisms that interact to prevent or favour the development of an allergic 2 
response to a food protein 3 
 4 
 5 
6 
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Summary and conclusions 1 
This review covered a number of approaches to prevent the development of food allergy. These are likely to 2 
interact. Figure 2 summarises how factors (including prenatal factors which have not been considered in this 3 
review) may interact to prevent or promote the food allergy development. Unlike in previous decades, national 4 
recommendations for food allergy prevention strategies now largely agree, particularly concerning hypoallergenic 5 
formula use and not delaying the introduction of allergenic foods. [26-29] However, while there is consensus that 6 
avoidance strategies are ineffective, guidelines do not provide any alternative strategies. There is a call for more 7 
high-quality data from robust RCTs. Some has already been provided and appears to support the concept that 8 
early consumption of allergenic food promotes the development of immune tolerance and a recent consensus 9 
statement supports this[47].  However, before recommendations are updated, it is important to understand how 10 
best to introduce preventive interventions in a community context, particularly since there may be significant 11 
numbers of children already sensitised by the time they are weaned. Given their different intervention strategies 12 
and populations investigated, combining the new RCT data into meta- or pooled analyses, will broaden their 13 
informational scope, and this is planned as part of the iFAAM study. However, even pooled, they may not 14 
provide data as to what dose of allergenic food should be given and for how long. Data from on-going studies on 15 
solid food introduction and nutritional supplementation may also provide a broader understanding of food allergy 16 
prevention. As studies have generally only focused on IgE mediated food allergy, their findings may not be 17 
applicable to preventing the development of non-IgE mediated food allergy conditions such as eosinophilic 18 
oesophagitis and food protein induced enterocolitis syndrome. Aetiology data for these conditions are lacking 19 
and RCTs similar to those carried out for IgE-mediated disease should be a future research priority in the field of 20 
food allergy.  21 
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